SynthesisAsian Pacific journal of cancer prevention : APJCP2023

Efficacy and Safety of Ibrutinib for Chronic Graft-Versus-Host Disease: A Systematic Review.

Damai Santosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.